We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Automated Anesthesia During Bronchoscopy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00571181
First Posted: December 11, 2007
Last Update Posted: September 23, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Hopital Foch
  Purpose
The purpose of this study is to compare manual administration of propofol and remifentanil and dual closed-loop using bispectral index as the control variable during rigid bronchoscopy.

Condition Intervention Phase
Anesthesia, General Device: Closed-loop system Device: TCI (Infusion Toolbox) Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Target-Controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by the Index Bispectral: Comparison Between Manual Perfusion and Automated Perfusion During Rigid Bronchoscopy

Resource links provided by NLM:


Further study details as provided by Hopital Foch:

Primary Outcome Measures:
  • Percentage of time with BIS in the desired range [ Time Frame: During the procedure ]

Secondary Outcome Measures:
  • consumption of propofol and remifentanil [ Time Frame: during the procedure ]
  • extubation time [ Time Frame: during the procedure ]
  • explicit memorisation [ Time Frame: postoperative day 2 ]

Enrollment: 66
Study Start Date: December 2007
Study Completion Date: September 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1 Device: Closed-loop system
Automatic delivery of propofol and remifentanil
Active Comparator: 2 Device: TCI (Infusion Toolbox)
TCI administration of propofol and remifentanil

Detailed Description:
The Bispectral Index (BIS) is an electroencephalogram-derived measure of anesthetic depth. We have built a combined closed-loop anesthesia system using BIS as the control variable, two proportional-integral-differential control algorithms, a propofol and a remifentanil target-controlled infusion systems as the control actuators. A recent study has shown that such system is able to provide clinically adequate anesthesia. The aim of the present study is to assess the system during rigid bronchoscopy. Two groups of patients are compared: one in which propofol and remifentanil are administered by the anesthesiologist using target-controlled infusion systems, and one in which propofol and remifentanil are administered automatically by the combined closed-loop anesthesia system. In both groups, the goal is to maintain BIS between 40 and 60, the recommended range during anesthesia by the manufacturer. We expect the combined closed-loop anesthesia system group to do similar or better.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients undergoing rigid bronchoscopy under general anesthesia

Exclusion Criteria:

  • pregnant women
  • allergy to propofol or remifentanil
  • neurological disorder
  • psychotrop treatment
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00571181


Locations
France
Service d'Anesthésie, Hôpital Foch
Suresnes, France, 92150
Sponsors and Collaborators
Hopital Foch
Investigators
Study Chair: Marc Fischler, MD Hopital Foch
  More Information

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Hopital Foch
ClinicalTrials.gov Identifier: NCT00571181     History of Changes
Other Study ID Numbers: 2007/14
EudraCT 2007-003157-82
First Submitted: December 9, 2007
First Posted: December 11, 2007
Last Update Posted: September 23, 2016
Last Verified: September 2016

Keywords provided by Hopital Foch:
Algorithms
Anesthesia, General/*methods
Anesthetics, Intravenous/*administration & dosage
Drug Delivery Systems/*methods/statistics & numerical data
Electroencephalography/drug effects/*methods/
Feasibility Studies
Propofol/*administration & dosage
Remifentanil/*administration & dosage
Bronchoscopy/*methods
Prospective Studies
Software

Additional relevant MeSH terms:
Anesthetics
Propofol
Remifentanil
Central Nervous System Depressants
Physiological Effects of Drugs
Hypnotics and Sedatives
Anesthetics, Intravenous
Anesthetics, General
Analgesics, Opioid
Narcotics
Analgesics
Sensory System Agents
Peripheral Nervous System Agents